Educational intervention for rural patients with early stage cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve care coordination for cancer patients from rural areas by providing a video educational intervention. Patients diagnosed with early stage breast, lung, or colon cancer will be randomized to receive this educational tool either before or after starting their adjuvant therapy. The study will assess changes in patients' knowledge about cancer, self-advocacy, and their perception of care coordination over a period of 4-6 months. The goal is to enhance the overall experience and outcomes for these patients during their treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18+ years of age
* Breast, lung, or colon cancer diagnosis
* Stage I, II or III cancer
* Adjuvant chemotherapy started \< 30 days or planned within the next 30 days
* Rural residence location in Vermont (outside Chittenden County)
* Proficient in English

Exclusion Criteria:

* History of prior malignancy treated with chemotherapy in last 3 years
* Known or suspected neuro-cognitive impairment
* Resident of Chittenden County, Vermont
* Patients with current diagnosis other than stage I, II or III breast, colon or lung cancer

Where it's running

• University of Vermont Cancer Center
  Burlington, Vermont, United States Recruiting

Study contacts

• Study coordinator: Randall F Holcombe
• Email: randall.holcombe@med.uvm.edu
• Phone: 18026563812

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.